Chemical Compound

Neamine

CAS Registry Number 3947-65-7
Back to search Request a Quote
Neamine chemical structure
Primary Record

Neamine

In stock
1,495 g
Purity
99.0 %
CAS
3947-65-7

Compound Identifiers & Properties

CAS
3947-65-7
PubChem CID
72392
SMILES
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O)O)N
Canonical SMILES
NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O

Names & Synonyms

  • Neamine
  • Neomycin A
  • Negamicin
  • Nebramycin X
  • Neamin
  • Dekamycin V
  • 3947-65-7
  • Neamine CRS
  • Neamine Disulfate Salt
  • Aminoglycoside ST-7
  • AC1L2HZM
  • NEAMINE [MI]
  • RefChem:832126
  • Neomycin Sulfate EP Impurity A
  • C12H26N4O6
  • D0I1NU
  • NEOMYCIN A, NEAMINE
  • (+)-NEAMINE
  • CHEBI:7489
  • DTXSID7023358
  • UNII-5981U00LY0
  • SCHEMBL219578
  • MFCD00023857
  • SYJXFKPQNSDJLI-HKEUSBCWSA-N
  • BDBM8580
  • CHEMBL427409
  • DTXCID603358
  • orb1981778
  • ST 7
  • 5981U00LY0
  • BRN 0026714
  • CID72392
  • HY-N7449
  • ZINC4095654
  • BBF-02599
  • EX-A10657
  • MSK158059
  • AKOS025311197
  • C12-H26-N4-O6
  • DB04808
  • J4.461J
  • ON32335
  • AN-10240
  • LS-96092
  • 2-Desoxy-4-O-(2,6-diamino-2,6-didesoxy-alpha-D-glucopyranosyl)-D-streptamin
  • 4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine
  • Neomycin Sulfate EP Impurity A (Neamine)
  • (2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4-diol
  • TOBRAMYCIN IMPURITY C [EP IMPURITY]
  • CS-0129171
  • NS00011537
  • 4-18-00-07474 (Beilstein Handbook Reference)
  • C01441
  • (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
  • 947N657
  • A824565
  • NEOMYCIN SULFATE IMPURITY A [EP IMPURITY]
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxyoxane-3,4-diol
  • D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-
  • Q6984256
  • N0001-003220
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
  • -5-AMINO-2-AMINOMETHYL-6- -TETRAHYDRO-PYRAN-3,4-DIOL
  • 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-D-streptamine
  • D-Streptamine, 2-deoxy-4-O-(2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl)-
  • (1'R,3'S,3S,5R,6R)-5-AMINO-2-AMINOMETHYL-6-(4,6-DIAMINO-2,3-DIHYDROXY-CYCLOHEXYLOXY)-TETRAHYDRO-PYRAN-3,4-DIOL
  • (1R,3S,3S,5R,6R)-5-Amino-2-aminomethyl-6-(4,6-diamino-2,3-dihydroxy-cyclohexyloxy)-tetrahydro-pyran-3,4-diol
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}oxane-3,4-diol
  • XXX
  • 2-Deoxy-4-O-(2,6-diamine-2,6-dideoxy-.alpha.-D-glucopyranosyl)-D-streptamine
  • 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-D-streptamine Disulfate Salt
  • 5-amino-2-(aminomethyl)-6-(4,6-diamino-2,3-dihydroxy-cyclohexoxy)-tetrahydropyran-3,4-diol
  • Framycetin Sulfate EP Impurity A; Neomycin Sulfate EP Impurity A; Tobramycin EP Impurity C
  • (1R,2S,3R,5S,6R)-3,5-Diamino-6-[(2,6-dideoxy-2,6-diamino-alpha-D-glucopyranosyl)oxy]cyclohexane-1,2-diol
  • (1S)-3alpha-[(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-4beta,6beta-diaminocyclohexane-1alpha,2beta-diol
  • (1S,2R,3R,4S,6R)-3-[(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-4,6-diaminocyclohexane-1,2-diol
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxyoxane-3,4-diol
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-tetrahydro-2H-pyran-3,4-diol
  • (2R,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-[[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy]tetrahydro-2H-pyran-3,4-diol
  • (2R,3S,4R,5R,6R)-5-Amino-2-aminomethyl-6-[[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexane-1-yl]oxy]-tetrahydro-2H-pyran-3,4-diol
  • (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-3,4-DIOL
  • 1-O-[(1alpha)-2beta,4beta-Diamino-5alpha,6beta-dihydroxycyclohexyl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
  • 1-O-[(1R)-2alpha,3beta-Dihydroxy-4alpha,6alpha-diaminocyclohexan-1beta-yl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
  • 1-O-[(1R,2R,3S,4R,6S)-2,3-Dihydroxy-4,6-diaminocyclohexan-1-yl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
  • 1-O-[(1R,2S,4R,5S,6R)-2,4-Diamino-5,6-dihydroxycyclohexyl]-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranose
  • 1404-04-2
  • 1406-04-8
  • 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine Disulfate Salt; Neomycin A Disulfate Salt
  • 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine; Neomycin A (6CI,7CI,8CI); (+)-Neamine; Dekamycin V; Neamin; Neamine; Nebramycin X; Negamicin; O-2,6-Diamino-2,6-dideoxy-a-D-glucopyranosyl-(1dagger'4)-1,3-diamino-1,2,3-trideoxy-D-myo-inositol; ST 7; Neomycin Imp. A (EP); GW 318764X
  • 3alpha,5alpha-Diamino-6beta-[(2,6-dideoxy-2,6-diamino-alpha-D-glucopyranosyl)oxy]cyclohexane-1alpha,2beta-diol
  • 998-897-5
  • O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-1,3-DIAMINO-1,2,3-TRIDEOXY-D-MYO-INOSITOL
  • O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL-(1->4)-1,3-DIAMINO-1,2,3-TRIDEOXY-D-MYO-INOSITOL